A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...
Upon reviewing repeated prostate cancer screenings, researchers observed the absence of suspicious MRI findings in over 86% of men who had prostate-specific antigen (PSA) levels of 3 ng/mL or higher ...
Whole-body screening MRI (wb-MRI) for asymptomatic patients has become a relevant topic for U.S. cancer centers. There is a growing number of for-profit centers offering wb-MRI scans for asymptomatic ...
Millions of men could benefit from a new, faster prostate cancer scan. The quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer in clinical trials as the current 30- to ...
MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...
A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
Following the PRECISION trial, prostate multiparametric MRI has been adopted as the first-line investigation for suspected ...
CURRENTLY, ROUTINE CANCER screenings only cover a small slice of cancers. For men in the US, there are guideline-backed screening tests for just two cancers: colorectal and lung cancer (lung ...
Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research. The findings are ...
Add Yahoo as a preferred source to see more of our stories on Google. One in eight men in the US will be diagnosed with prostate cancer, and one in 44 will die from it.Composite: The Guardian/Getty ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...